[go: up one dir, main page]

SV2009002876A - Derivados de triazol como inhibidores de 11-beta-hidroxiesteroide-deshidrogenasa-1 - Google Patents

Derivados de triazol como inhibidores de 11-beta-hidroxiesteroide-deshidrogenasa-1

Info

Publication number
SV2009002876A
SV2009002876A SV2008002876A SV2008002876A SV2009002876A SV 2009002876 A SV2009002876 A SV 2009002876A SV 2008002876 A SV2008002876 A SV 2008002876A SV 2008002876 A SV2008002876 A SV 2008002876A SV 2009002876 A SV2009002876 A SV 2009002876A
Authority
SV
El Salvador
Prior art keywords
inhibitors
hydroxiesteroide
dehydrogenasa
beta
triazol derivatives
Prior art date
Application number
SV2008002876A
Other languages
English (en)
Inventor
Sherman T Waddell
Nancy J Kevin
James M Baldovec
Xin Gu
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SV2009002876A publication Critical patent/SV2009002876A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LOS DERIVADOS TRIAZOL DE FÓRMULA ESTRUCTURAL I SON INHIBIDORES SELECTIVOS DE LA 11BELTA-HIDROXIESTEROIDE-DEHIDROGENASA-1. LOS COMPUESTOS SON ÚTILES PARA EL TRATAMIENTO DE DIABETES, TAL COMO DIABETES NO DEPENDIENTE DE LA INSULINA (NIDDM), HIPERGLUCEMIA, OBESIDAD, RESISTENCIA A INSULINA, DISLIPIDEMIA, HIPERLIPIDEMIA, HIPERTENSIÓN, SÍNDROME METABÓLICO Y OTROS SÍNTOMAS ASOCIADOS CON NIDDM
SV2008002876A 2005-10-20 2008-04-18 Derivados de triazol como inhibidores de 11-beta-hidroxiesteroide-deshidrogenasa-1 SV2009002876A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72872305P 2005-10-20 2005-10-20

Publications (1)

Publication Number Publication Date
SV2009002876A true SV2009002876A (es) 2009-02-19

Family

ID=37963190

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2008002876A SV2009002876A (es) 2005-10-20 2008-04-18 Derivados de triazol como inhibidores de 11-beta-hidroxiesteroide-deshidrogenasa-1

Country Status (18)

Country Link
US (1) US7981910B2 (es)
EP (1) EP1940393B1 (es)
JP (1) JP5036722B2 (es)
KR (1) KR20080059236A (es)
CN (2) CN103724335A (es)
AU (1) AU2006304434B2 (es)
BR (1) BRPI0617501A2 (es)
CA (1) CA2625871C (es)
CR (1) CR9931A (es)
EC (1) ECSP088384A (es)
IL (1) IL190436A0 (es)
MA (1) MA30201B1 (es)
NI (1) NI200800069A (es)
NO (1) NO20082278L (es)
RU (1) RU2008119842A (es)
SV (1) SV2009002876A (es)
WO (1) WO2007047625A2 (es)
ZA (1) ZA200802104B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7834178B2 (en) 2006-03-01 2010-11-16 Bristol-Myers Squibb Company Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
KR20090047458A (ko) 2006-08-08 2009-05-12 사노피-아벤티스 아릴아미노아릴-알킬-치환된 이미다졸리딘-2,4-디온, 이의 제조방법, 이들 화합물을 포함하는 약제 및 이의 용도
US7727978B2 (en) 2006-08-24 2010-06-01 Bristol-Myers Squibb Company Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
AU2008241527B2 (en) * 2007-04-18 2014-02-13 Merck Sharp & Dohme Llc Triazole derivatives which are Smo antagonists
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
UY31968A (es) 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
FR2942797B1 (fr) * 2009-03-03 2011-04-29 Pf Medicament Derives de benzothiazines, leur preparation et leur application a titre de medicaments
ES2350077B1 (es) 2009-06-04 2011-11-04 Laboratorios Salvat, S.A. Compuestos inhibidores de 11beta-hidroxiesteroide deshidrogenasa de tipo 1.
WO2011023754A1 (en) 2009-08-26 2011-03-03 Sanofi-Aventis Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120053A1 (de) 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CN104961696A (zh) * 2015-07-13 2015-10-07 佛山市赛维斯医药科技有限公司 一类卤苯三氮唑亚砜类11β-HSD1抑制剂、制备方法及其用途
CN104961697A (zh) * 2015-07-13 2015-10-07 佛山市赛维斯医药科技有限公司 末端卤素取代的三氮唑亚砜类化合物、其制备方法及其用途
CN104910083A (zh) * 2015-07-13 2015-09-16 佛山市赛维斯医药科技有限公司 烷氧苯基三氮唑亚砜类11β-HSD1抑制剂、制备方法及其用途
CN105001170A (zh) * 2015-07-13 2015-10-28 佛山市赛维斯医药科技有限公司 末端腈基取代的三氮唑亚砜类化合物、其制备方法及其用途
CN104910084A (zh) * 2015-07-13 2015-09-16 佛山市赛维斯医药科技有限公司 末端胺基取代的三氮唑亚砜类化合物、其制备方法及其用途
CN104987312A (zh) * 2015-07-13 2015-10-21 佛山市赛维斯医药科技有限公司 一类胺基苯三氮唑亚砜类11β-HSD1抑制剂及其用途
CN105001171A (zh) * 2015-07-13 2015-10-28 佛山市赛维斯医药科技有限公司 一类硝基苯三氮唑亚砜类11β-HSD1抑制剂及其用途
CN104987313A (zh) * 2015-07-13 2015-10-21 佛山市赛维斯医药科技有限公司 一类末端取代的三氮唑亚砜类化合物、其制备方法及其用途
CN105017170A (zh) * 2015-07-13 2015-11-04 佛山市赛维斯医药科技有限公司 一类腈基苯三氮唑亚砜类11β-HSD1抑制剂及其用途
CN104926745A (zh) * 2015-07-14 2015-09-23 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端卤代苄基类结构的化合物及其用途
CN104974103A (zh) * 2015-07-14 2015-10-14 佛山市赛维斯医药科技有限公司 一类含苯并异恶唑和烷氧苯基类结构的化合物及其用途
CN105017135A (zh) * 2015-07-19 2015-11-04 佛山市赛维斯医药科技有限公司 一类二吡啶叔醇结构的11β-HSD1抑制剂、制备方法及其用途
CN105001152A (zh) * 2015-07-19 2015-10-28 佛山市赛维斯医药科技有限公司 一类二甲胺基二吡啶叔醇结构的11β-HSD1抑制剂及其用途
US11512067B2 (en) * 2017-09-14 2022-11-29 Daiichi Sankyo Company, Limited Compound having cyclic structure
EP3721402A4 (en) 2017-12-05 2021-08-04 Rapidsos Inc. EMERGENCY MANAGEMENT SOCIAL MEDIA CONTENT
US11917514B2 (en) 2018-08-14 2024-02-27 Rapidsos, Inc. Systems and methods for intelligently managing multimedia for emergency response

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2397B1 (en) * 2002-12-20 2007-06-17 ميرك شارب اند دوم كوربوريشن Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors

Also Published As

Publication number Publication date
CA2625871C (en) 2014-07-08
RU2008119842A (ru) 2009-12-10
EP1940393A4 (en) 2008-12-17
AU2006304434A1 (en) 2007-04-26
AU2006304434B2 (en) 2012-04-05
ECSP088384A (es) 2008-05-30
JP5036722B2 (ja) 2012-09-26
IL190436A0 (en) 2008-12-29
CN101291672A (zh) 2008-10-22
EP1940393B1 (en) 2012-07-25
KR20080059236A (ko) 2008-06-26
BRPI0617501A2 (pt) 2011-07-26
US7981910B2 (en) 2011-07-19
MA30201B1 (fr) 2009-02-02
WO2007047625A2 (en) 2007-04-26
JP2009512704A (ja) 2009-03-26
WO2007047625A3 (en) 2007-10-11
US20090258913A1 (en) 2009-10-15
CA2625871A1 (en) 2007-04-26
NI200800069A (es) 2008-06-25
EP1940393A2 (en) 2008-07-09
CN103724335A (zh) 2014-04-16
NO20082278L (no) 2008-07-17
CR9931A (es) 2008-08-21
ZA200802104B (en) 2009-08-26

Similar Documents

Publication Publication Date Title
SV2009002876A (es) Derivados de triazol como inhibidores de 11-beta-hidroxiesteroide-deshidrogenasa-1
ECSP088820A (es) Síntesis de acil-amino-alquenilen-amidas utiles como antagonistas de la sustancia p.
ECSP088145A (es) Derivados bicíclicos como inhibidores de la cinasa p38
EA200800549A1 (ru) Региоселективный способ получения бензимидазолтиофенов
ECSP109945A (es) Nuevos herbicidas
ECSP12011799A (es) Compuestos de espiropiperidina y uso farmacéutico de los mismos
EA201000272A1 (ru) Трициклические мостиковые производные циклопентадиенона, как гербициды
EA201170872A1 (ru) Ингибиторы протеинкиназы
DK2078010T3 (da) Polycyklisk heteroaryl-substituerede triazoler, der er anvendelige som axl-hæmmere
CL2011000087A1 (es) Compuestos derivados de heteroarilo sustituido, inhibidores de los receptores dgat1; composicion farmaceutica; y su uso para tratar la diabetes tipo ll y obesidad.
ECSP088536A (es) DERIVADOS DE PIRIDO-, PIRAZO- Y PIRIMIDO-PIRIMIDINA COMO INHIBIDORES DE mTOR
NO20090173L (no) Kondensert spiroketalderivat og anvendelse derav som legemiddel for a behandle diabetes
CL2009001063A1 (es) Uso de una combinacion de un compuesto derivado de n-quinoliniloxifenil-n-fenilciclopropanodicarboxamida y un inhibidor de erbb seleccionado entre lapatinib, erlotinib, gefitinib, trastuzumab, cetuximab, para eltratamiento de canceres.
EA201000395A1 (ru) Фунгицидные производные 2-алкилтио-2-хинолинилоксиацетамида
CR20110028A (es) Derivados de pirimidina como inhibidores de cinasa
BRPI0914772A2 (pt) compostos heterocíclicos 1,2-dissubstituídos
EA201000396A1 (ru) Новые фунгициды
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
DK1846394T3 (da) Pyrazolylaminopyridinderivater, der er egnede som kinaseinhibitorer
NO20075706L (no) Pyrrolopyridinbaserte inhibitorer av dipeptidylpeptidase IV og metoder
NO20082209L (no) Homo- og heterocykliske forbindelser anvendbare som CETP-inhibitorer
UA104438C2 (uk) Спосіб одержання дабігатрану і його проміжних сполук
ECSP11011245A (es) Novedosos herbicidas
EA201000204A1 (ru) Производные циклопропиламида
ECSP11011133A (es) Nuevos herbicidas.

Legal Events

Date Code Title Description
FD Lapse